Showing results (451-460 of 993) with videos related to

Sort By:
Pageof 100
Current Cancer Drug Targets|October 31, 2013
Emerging role of mucins in epithelial to mesenchymal transitionMoorthy P Ponnusamy, Parthasarathy Seshacharyulu, Imayavaramban Lakshmanan, et al.
Molecular Cell|May 13, 2008
Structures of DNA polymerase beta with active-site mismatches suggest a transient abasic site intermediate during misincorporationVinod K Batra, William A Beard, David D Shock, et al.
Carcinogenesis|November 14, 2016
Genetic variants of mucins: unexplored conundrumSushil Kumar, Eric Cruz, Suhasini Joshi, et al.
Cancer Treatment Reviews|January 28, 2015
Emerging potential of natural products for targeting mucins for therapy against inflammation and cancerMuzafar A Macha, Shiv Ram Krishn, Rahat Jahan, et al.
Biomolecules|March 28, 2024
The Expression of the Claudin Family of Proteins in Colorectal CancerKristin E Cox, Shanglei Liu, Robert M Hoffman, et al.
Expert Opinion on Therapeutic Targets|May 27, 2023
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?Sushanta Halder, Soumi Basu, Shobhit P Lall, et al.
Cancer|March 22, 2012
DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinomaTomofumi Hamada, Masahiro Nomura, Yoshiaki Kamikawa, et al.
Carcinogenesis|May 25, 2012
Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesisNavneet Momi, Sukhwinder Kaur, Moorthy P Ponnusamy, et al.
Gynecologic Oncology|January 1, 1993
A portable tensiometer for assessing surgeon's knot tying techniqueE K Batra, P T Taylor, D A Franz, et al.
Nuclear Medicine and Biology|November 14, 1997
In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: comparison with its murine parentC J Reist, S K Batra, C N Pegram, et al.
Pageof 100